Anacor is a privately held biopharmaceutical company developing small molecule therapeutics derived from our boron chemistry platform.

Our principal investors include:

• Rho Ventures


• Venrock Associates


• Care Capital Investments


• Aberdare Ventures

For more information, contact ir@anacor.com